Innovative Diagnostics Aptitude Medical Systems is developing lab-quality, decentralized diagnostic tests for multiple conditions, including Covid-19 and flu, allowing healthcare providers and potentially retail outlets to perform high-quality diagnostics outside traditional labs.

Strategic Partnerships The company's exclusive distribution agreement with SEKISUI Diagnostics and FDA Emergency Use Authorization highlight its growing footprint and credibility, presenting opportunities to expand into new markets and distribute additional diagnostics solutions.

Strong Funding Support With over 10 million dollars in grants from the Bill & Melinda Gates Foundation and additional financing, Aptitude has the capital to accelerate product deployment and clinical validation, increasing its attractiveness to partners and resellers.

Market Expansion Recent launches of Covid and flu tests, along with regulatory approvals, position Aptitude to tap into the high-demand, broad market for rapid, portable diagnostics, especially in the current public health climate.

Technological Edge Utilizing cloud-based infrastructure and advanced web technologies, Aptitude's solutions are scalable and accessible, enabling partnerships with healthcare providers, labs, and retail channels for wide-reaching diagnostic deployment.